These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22231458)

  • 21. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
    Elmaagacli AH; Koldehoff M; Landt O; Beelen DW
    Bone Marrow Transplant; 2008 May; 41(9):821-6. PubMed ID: 18209723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.
    Elmaagacli AH; Koldehoff M; Hindahl H; Steckel NK; Trenschel R; Peceny R; Ottinger H; Rath PM; Ross RS; Roggendorf M; Grosse-Wilde H; Beelen DW
    Transplantation; 2006 Jan; 81(2):247-54. PubMed ID: 16436969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idarubicin-intensified BUCY2 regimens may lower relapse rate and improve survival in patients undergoing allo-SCT for high-risk hematological malignancies: a retrospective analysis.
    Hong M; Wu Q; Hu C; Fang J; You Y; Zhong Z; Zou P; Hu Y; Xia L
    Bone Marrow Transplant; 2012 Feb; 47(2):196-202. PubMed ID: 21441957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
    Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
    Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.
    Wu GQ; Zhao YM; Lai XY; Luo Y; Tan YM; Shi JM; Li L; Zheng WY; Zhang J; Hu XR; Jin AY; He JS; Xie WZ; Ye XJ; Cai Z; Lin MF; Huang H
    Bone Marrow Transplant; 2010 Oct; 45(10):1514-21. PubMed ID: 20173784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.
    Björkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Gahrton G
    J Clin Oncol; 2011 Aug; 29(22):3016-22. PubMed ID: 21730266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?
    Mehta J; Gordon LI; Tallman MS; Winter JN; Evens AM; Frankfurt O; Williams SF; Grinblatt D; Kaminer L; Meagher R; Singhal S
    Bone Marrow Transplant; 2006 Jul; 38(2):95-100. PubMed ID: 16751789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation.
    Granell M; Urbano-Ispizua A; Pons A; Aróstegui JI; Gel B; Navarro A; Jansa S; Artells R; Gaya A; Talarn C; Fernández-Avilés F; Martínez C; Rovira M; Carreras E; Rozman C; Juan M; Yagüe J; Montserrat E; Monzó M
    Blood; 2008 Nov; 112(10):4337-42. PubMed ID: 18772453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical contrasting study on hematopoietic stem cell transplantation from HLA-identical sibling and partially HLA-mismatched related donors].
    Wang LH; Ren HY; Li Y; Qiu ZX; Cen XN; Ou JP; Xu WL; Wang MJ; Wang Y; Dong YJ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):507-11. PubMed ID: 19112911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis.
    Chiusolo P; Bellesi S; Piccirillo N; Giammarco S; Marietti S; De Ritis D; Metafuni E; Stignani M; Baricordi OR; Sica S; Leone G; Rizzo R
    Bone Marrow Transplant; 2012 Jan; 47(1):120-4. PubMed ID: 21399669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT.
    Markiewicz M; Siekiera U; Karolczyk A; Szymszal J; Helbig G; Wojnar J; Dzierzak-Mietla M; Kyrcz-Krzemien S
    Bone Marrow Transplant; 2009 Feb; 43(4):293-300. PubMed ID: 18850018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival.
    Ramírez P; Brunstein CG; Miller B; Defor T; Weisdorf D
    Bone Marrow Transplant; 2011 Jul; 46(7):981-6. PubMed ID: 20921943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9.
    Elmaagacli AH; Koldehoff M; Beelen DW
    Bone Marrow Transplant; 2009 Sep; 44(5):295-302. PubMed ID: 19252531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
    Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
    Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
    Clausen J; Kircher B; Auberger J; Schumacher P; Ulmer H; Hetzenauer G; Wolf D; Gastl G; Nachbaur D
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
    Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features of 62 allogeneic stem cell transplantations; the evaluation of prognostic factor in a single institution.
    Kawasaki K; Kosaka Y; Nakamura H
    Kobe J Med Sci; 2003; 49(1-2):1-10. PubMed ID: 12698016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.